Tag: COVAXIN

Coronavirus vaccine: ICMR fast-tracks COVAXIN procedure, aims at August 15 launch

KV Prasad Jun 13, 2022, 06:35 AM IST (Published)

Listen to the Article (6 Minutes)

The Indian Council of Medical Research has written to clinical trial sites to fast track all approvals and initiate enrolment for clinical trials of the indigenous COVID-19 vaccine, Covaxin, by July 7, so that “results of the clinical trials can be launched by August 15.”

ICMR and Bharat Biotech International Limited are jointly working for the preclinical as well as clinical development of the vaccine.

ICMR has written to all clinical trial partners to fast track the enrollment process.

“It is envisaged to launch the vaccine for public use latest by August 15 after completion of all clinical trials. BBIL is working expeditiously to meet the target however the final outcome will depend on the cooperation of all clinical sites involved in this project,” the ICMR letter said, adding that non-compliance would be “viewed seriously.”

ICMR and Bharat Biotech declined to comment on the letter.

Elon Musk forms several ‘X Holdings’ companies to fund potential Twitter buyout

3 Mins Read

Thursday’s filing dispelled some doubts, though Musk still has work to do. He and his advisers will spend the coming days vetting potential investors for the equity portion of his offer, according to people familiar with the matter

KV Prasad Journo follow politics, process in Parliament and US Congress. Former Congressional APSA-Fulbright Fellow

India’s first COVID-19 vaccine candidate COVAXIN gets DCGI approval; human trials to begin in July

KV Prasad Jun 13, 2022, 06:35 AM IST (Published)

Listen to the Article (6 Minutes)

India’s first COVID-19 vaccine candidate COVAXIN has received the approval of drug regulator DCGI for phase I and II of human clinical trials. The drug has been developed by Bharat Biotech.

Human clinical trials are scheduled to start across India in July 2020.

It has been developed in collaboration with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV). The SARS-CoV-2 strain was isolated in NIV, Pune and transferred to Bharat Biotech.

The indigenous, inactivated vaccine has been developed and manufactured by Bharat Biotech.

A number of drug manufacturers across the globe are working to find a cure for coronavirus, but no pharmaceutical firm has won the race yet.

Earlier Monday Reuters reported that China’s military has received the greenlight to use a COVID-19 vaccine candidate developed by its research unit and CanSino Biologics after clinical trials proved it was safe and showed some efficacy.

Several drugs have been tested for their effectiveness against COVID-19, the disease resulting from coronavirus, but they have fallen short. Gilead Sciences’ remdesivir has been found to be effective in reducing the time spent in hospital  by infected patients, but a cure is yet to find.

COVID-19 has infected more than 10 million people globally and has killed half a million.

Elon Musk forms several ‘X Holdings’ companies to fund potential Twitter buyout

3 Mins Read

Thursday’s filing dispelled some doubts, though Musk still has work to do. He and his advisers will spend the coming days vetting potential investors for the equity portion of his offer, according to people familiar with the matter

KV Prasad Journo follow politics, process in Parliament and US Congress. Former Congressional APSA-Fulbright Fellow